|Articles|August 4, 2019

Avedro, Inc., company update: Epi-on crosslinking (CXL) and PiXL technology

ICYMI: Here's what's in the 2019 pipeline

Rajesh Rajpal, MD, Chief Medical Officer of Avedro, Inc., provides a company update on Epi-on crosslinking (CXL) and PiXL technology during the 2019 ASCRS conference in San Diego.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME